MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Biocept ROA 2011-2026 | BIOC
ROA Jährlich Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -103.93 | -4.67 | -37.53 | -141.76 | -280.81 | -292.91 | -242.79 | -160.1 | -240.82 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -4.67 | -292.91 | -167.26 |
ROA Vierteljährlich Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.2 | -70.05 | -31.69 | -32.7 | -22.86 | -9.2 | 0.55 | -36.96 | -73.47 | -107.37 | -112.54 | -144.76 | -248.79 | -352.83 | -456.86 | -493.37 | -632.96 | -772.55 | -912.13 | -920.19 | -717.95 | -513.97 | -525.57 | -504.02 | -667.93 | -833.57 | -783.64 | -772.01 | -688.84 | -605.67 | -522.51 | -538.02 | -620.58 | -703.14 | -785.7 | -912.48 | -885.39 | -791.72 | -694.37 | -508.47 | -293.37 | -144.84 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.55 | -920.19 | -464.61 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | - | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 29.8 | -3.87 % | $ 321 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-37.07 | - | - | $ 79.8 M | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.13 | -3.54 % | $ 1.44 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | - | - | $ 914 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
5.03 | $ 219.93 | 0.09 % | $ 161 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 104.25 | 0.08 % | $ 4.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
8.64 | - | - | $ 26.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 209.75 | 2.09 % | $ 23.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 19.51 | -5.18 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 11.07 | 1.37 % | $ 314 M | Israel |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 103.42 | - | $ 19.2 B | USA |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.82 | - | $ 7.98 M | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 67.04 | - | $ 4.64 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 23.02 | - | $ 696 M | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | - | -0.62 % | $ 28.7 B |  Schweiz |
 |
Guardant Health
GH
|
-29.37 | $ 106.6 | 1.65 % | $ 13.1 B | USA |
 |
NeoGenomics
NEO
|
-4.81 | $ 11.47 | - | $ 1.45 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
-39.28 | - | -0.5 % | $ 20.7 B | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.25 | 2.05 % | $ 868 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | - | -9.16 % | $ 8.49 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 32.03 | -2.72 % | $ 20 B | Niderland |
 |
IDEXX Laboratories
IDXX
|
26.96 | - | - | $ 53.5 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 117.01 | -1.95 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 176.27 | - | $ 32 B | USA |
|
Biodesix
BDSX
|
-44.15 | - | - | $ 1.33 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 289.4 | 1.75 % | $ 24.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 3.56 | -4.56 % | $ 1.91 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | - | - | $ 11 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
43.3 | - | -3.13 % | $ 1.19 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.23 | - | $ 5.12 M | USA |
 |
Bioventus
BVS
|
-19.27 | $ 8.04 | - | $ 504 M | USA |